PFE
Pfizer, Inc.Close $25.66EOD onlyThis page reflects PFE options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Consensus-supported lens with chain history and key metrics in the rail.
Flow Verdict
Watch next session: $28.50 call OI buildup; Flow reaction near $30 strike
Flow Summary
Net premium: +$6.3M bullish
P/C volume ratio: 0.40 — extremely call-dominant
P/C OI ratio: 0.82 — moderate put lean in positioning
Notable Prints
Read-through: This is an aggressive OTM call purchase (8.6% above spot). The 4.8x volume/OI ratio suggests new positioning. Given the overall bullish flow regime, this is likely a directional bet targeting a move toward $30-31.
Read-through: High volume at the at-the-money put. In the context of strong call buying, this is more likely a short put sale (bullish income play) rather than protective buying. The IV of 24.2% is below the term structure average, supporting a sale interpretation.
Read-through: Volume in the May monthly, which contains the next earnings date (5/5/26 est.). The elevated IV (30.9% vs. ~26% for April) suggests this is earnings-related positioning. Likely a hedge against a post-earnings drop.
Institutional Positioning
Call additions: $28, $27, and $30 calls across April expiries, per premium flow data.
Put additions: Minimal recent put buying; large legacy OI at $20-$25 puts.
GEX/DEX consistency: Yes — Positive GEX of +$222.9M aligns with bullish flow and creates a pinning effect near current price.
OI clusters: Major call OI at $28 (87K) and $30 (54K). Major put OI walls at $20 (60K), $24 (52K), and $25 (51K).
Hedging evidence: The massive put OI at $20-$25 represents a large, longer-term hedge or legacy positioning. Recent hedging is light, focused on earnings (May $29P).
Max pain context: Spot ($28.08) is above max pain ($26), creating gravitational pull lower. However, strong bullish flow is pushing against this.
Signal vs Noise
Key Conclusions
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.